Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q3 2018 Earnings

8AugConfirmed

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-0.62

-0.56

-0.5

-0.44

Details

Expected EPS

-0.45

Actual EPS

-0.51

Surprise EPS

-0.06

Surprise Percent

+13.33%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.51 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.